News on December 31, 2019 from | Psychedelics Today
In this episode, Joe interviews Dr. Peter Addy, Licensed Mental Health Counselor out of Washington. In the show, they talk about the research and therapeutic use of Salvia.
3 Key Points:
- Salvinorin A is the active molecule that causes the psychedelic experiential reports, although there are at least a dozen unique compounds in the Salvia plant.
- In a recreational setting, Salvia is usually smoked, but in the Mazatec culture, they do not smoke it, they use a sublingual method.
- The clinical applications of Salvia are tricky right now. It’s not easy to get funding for psychedelic research.
Support the show
- Leave us a review on iTunes
- Share us with your friends – favorite podcast, etc
- Join our Facebook group – Psychedelics Today group – Find the others and create community.
Show Notes About Peter
- Peter helped found the Yale Psychedelic Speaker Series
- The main goal was to normalize talking about psychedelic research as research
- Peter joined the pharmacology lab for his post doctoral research on Salvia
- The team was mainly studying THC but were also studying Ketamine
- He wanted to bring in MDMA and Psilocybin research
- Peter attended The Institute of Transpersonal Psychology
- As a psychologist, Peter focused heavily on feedback and experience
- It all started when Peter stumbled across a dusty book in the library as a Freshman,